Neuropsychiatric disorders following SARS-CoV-2 infection

Several large-scale electronic health records studies have reported increased diagnostic rates for neuropsychiatric disorders following Coronavirus disease 2019 [COVID-19 or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 infection)], but many questions remain. To highlight the issues, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrison, PJ, Taquet, M
Formato: Journal article
Lenguaje:English
Publicado: Oxford University Press 2023
_version_ 1826310167139975168
author Harrison, PJ
Taquet, M
author_facet Harrison, PJ
Taquet, M
author_sort Harrison, PJ
collection OXFORD
description Several large-scale electronic health records studies have reported increased diagnostic rates for neuropsychiatric disorders following Coronavirus disease 2019 [COVID-19 or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 infection)], but many questions remain. To highlight the issues, we selectively review this literature, focussing on mood disorder, anxiety disorder, psychotic disorder, and cognitive impairment (‘brain fog’). Eight key questions are addressed, comprising: (i) the nature and magnitude of the risks; (ii) their association with severity of infection; (iii) their duration; (iv) whether the risks differ between adults and children, or between men and women; (v) whether prior vaccination protects against them; (vi) the risk profile associated with different SARS-CoV-2 strains; (vii) what the underlying mechanisms might be; and (viii) whether the sequelae can be predicted. We consider the major unknowns, the limitations of electronic health records for research in this area, and the use of additional approaches to help characterise and understand the neuropsychiatric burden of COVID-19.
first_indexed 2024-03-07T07:48:05Z
format Journal article
id oxford-uuid:2c89bf19-6dbe-4f4f-ab0b-d0c7a84d4e83
institution University of Oxford
language English
last_indexed 2024-03-07T07:48:05Z
publishDate 2023
publisher Oxford University Press
record_format dspace
spelling oxford-uuid:2c89bf19-6dbe-4f4f-ab0b-d0c7a84d4e832023-06-22T08:25:48ZNeuropsychiatric disorders following SARS-CoV-2 infectionJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:2c89bf19-6dbe-4f4f-ab0b-d0c7a84d4e83EnglishSymplectic ElementsOxford University Press2023Harrison, PJTaquet, MSeveral large-scale electronic health records studies have reported increased diagnostic rates for neuropsychiatric disorders following Coronavirus disease 2019 [COVID-19 or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 infection)], but many questions remain. To highlight the issues, we selectively review this literature, focussing on mood disorder, anxiety disorder, psychotic disorder, and cognitive impairment (‘brain fog’). Eight key questions are addressed, comprising: (i) the nature and magnitude of the risks; (ii) their association with severity of infection; (iii) their duration; (iv) whether the risks differ between adults and children, or between men and women; (v) whether prior vaccination protects against them; (vi) the risk profile associated with different SARS-CoV-2 strains; (vii) what the underlying mechanisms might be; and (viii) whether the sequelae can be predicted. We consider the major unknowns, the limitations of electronic health records for research in this area, and the use of additional approaches to help characterise and understand the neuropsychiatric burden of COVID-19.
spellingShingle Harrison, PJ
Taquet, M
Neuropsychiatric disorders following SARS-CoV-2 infection
title Neuropsychiatric disorders following SARS-CoV-2 infection
title_full Neuropsychiatric disorders following SARS-CoV-2 infection
title_fullStr Neuropsychiatric disorders following SARS-CoV-2 infection
title_full_unstemmed Neuropsychiatric disorders following SARS-CoV-2 infection
title_short Neuropsychiatric disorders following SARS-CoV-2 infection
title_sort neuropsychiatric disorders following sars cov 2 infection
work_keys_str_mv AT harrisonpj neuropsychiatricdisordersfollowingsarscov2infection
AT taquetm neuropsychiatricdisordersfollowingsarscov2infection